AVTR250117P32500
- 10.60
- 0.000.00%
Avantor Newsroom
Evercore Maintains Avantor(AVTR.US) With Buy Rating, Cuts Target Price to $26
RBC Capital Reaffirms Their Buy Rating on Avantor (AVTR)
Avantor Is Maintained at Overweight by Wells Fargo
Morgan Stanley Maintains Avantor(AVTR.US) With Buy Rating, Maintains Target Price $27
A Quick Look at Today's Ratings for Avantor(AVTR.US), With a Forecast Between $25 to $28
Avantor's Attractive Valuation and Decreasing Leverage Support Buy Rating
Stifel Nicolaus Sticks to Their Buy Rating for Avantor (AVTR)
Baird Maintains Outperform on Avantor, Lowers Price Target to $26
Goldman Sachs Maintains Avantor(AVTR.US) With Buy Rating, Cuts Target Price to $26
TD Cowen Maintains Avantor(AVTR.US) With Buy Rating, Cuts Target Price to $28
Avantor Maintains Buy Rating Amid Strong Bioprocess Performance and Attractive Valuation Despite Sector Challenges
Avantor Is Maintained at Overweight by Barclays
Avantor Analyst Ratings
Barclays Maintains Avantor(AVTR.US) With Buy Rating, Cuts Target Price to $25
Morgan Stanley Maintains Avantor(AVTR.US) With Buy Rating, Cuts Target Price to $28
Morgan Stanley Sticks to Their Buy Rating for Avantor (AVTR)
Barclays Maintains Avantor(AVTR.US) With Buy Rating, Maintains Target Price $28
Avantor (AVTR) Gets a Buy From Barclays
RBC Capital Maintains Avantor(AVTR.US) With Buy Rating, Maintains Target Price $34
UBS Maintains Avantor(AVTR.US) With Buy Rating, Raises Target Price to $29